SECsense Logo

Centessa Pharmaceuticals PLC 8-K Report: Key Insights for Investors

$CNTA
Form 8-K
Filed on: 2024-12-30
Source
Centessa Pharmaceuticals PLC 8-K Report: Key Insights for Investors

Based on the provided section of the financial report, here are the key insights and important information extracted:

  1. Entity Information:
  • Company Name: Centessa Pharmaceuticals PLC
  • CIK (Central Index Key): 0001847903
  • SEC Filing Type: 8-K
  • File Number: 001-40445
  • Employer Identification Number (EIN): 98-1612294
  • Address: 3rd Floor, 1 Ashley Road, Altrincham, Cheshire WA14 2DT, GB
  • Contact Number: +1 (617) 468-5770
  1. Stock Information:
  • Common Stock: The nominal value is £0.002 per share.
  • American Depositary Shares (ADS): Each ADS represents one ordinary share with the same nominal value (£0.002).
  • Ticker Symbol: CNTA (both for common stock and American Depositary Shares).
  • Exchange: NASDAQ.
  1. Reporting Period:
  • The report pertains to a specific date: December 30, 2024. There are no start or end dates specified beyond this date, indicating it is likely a single date report.
  1. Segments:
  • The report references two classes of stock:
    • Common Stock
    • American Depositary Shares
  1. XBRL Context:
  • There are multiple contexts identified for the financial data, suggesting detailed reporting on different stock classes.

Insights:

  • Centessa Pharmaceuticals PLC is actively reporting their financials to the SEC and is publicly traded on NASDAQ under the ticker CNTA.
  • The presence of both common stock and American Depositary Shares indicates that the company is catering to both domestic and international investors.
  • The nominal value of shares is relatively low (£0.002), which may suggest a growth-oriented approach or a strategy to appeal to a wider range of investors.
  • The date of the report signifies that it may contain timely information relevant to investors regarding the company's financial health or business developments as of the end of 2024.

This analysis provides a snapshot of Centessa Pharmaceuticals PLC's stock structure and recent filing activity relevant to potential investors and stakeholders.